{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:59:52Z","timestamp":1771477192604,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.spen.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T13:14:29Z","timestamp":1518614069000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Movement Disorders and Neurometabolic Diseases"],"prefix":"10.1016","volume":"25","author":[{"given":"Celanie K.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2018.02.003_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-014-0177-6","article-title":"Rare inborn errors of metabolism with movement disorders: A case study to evaluate the impact upon quality of life and adaptive functioning","volume":"9","author":"Eggink","year":"2014","journal-title":"Orphan J Rare Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib2","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10545-009-1194-9","article-title":"Inborn errors of metabolism and motor disturbances in children","volume":"32","author":"Garcia-Carzola","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejpn.2011.04.005","article-title":"Movement disorder emergencies in childhood","volume":"15","author":"Kirkham","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dmcn.12339","article-title":"Status dystonicus: A practice guide","volume":"56","author":"Allen","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib5","first-page":"1","article-title":"Australian children living with rare diseases: Experiences of diagnosis and perceived consequences of diagnostic delays","volume":"12","author":"Zuarynski","year":"2017","journal-title":"Orphan J Rare Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1469-7580.2000.19640519.x","article-title":"Functional anatomy of movement disorders","volume":"196","author":"Crossman","year":"2000","journal-title":"J Anat"},{"key":"10.1016\/j.spen.2018.02.003_bib7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(06)70494-X","article-title":"Seminar on choreas","volume":"5","author":"Cardoso","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejpn.2009.11.005","article-title":"Movement disorders in neuro-metabolic diseases","volume":"14","author":"Gouider-Khouja","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mdc3.12100","article-title":"The new classification system for the dystonias: Why was it needed and how was it developed?","volume":"1","author":"Jinnah","year":"2014","journal-title":"Mov Dis Clin Prac"},{"key":"10.1016\/j.spen.2018.02.003_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: A consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2018.02.003_bib11","doi-asserted-by":"crossref","unstructured":"Jinnah H.A., Neychev V., Hess E.J. The anatomical basis for dystonia: The motor network model. Louis E.D., editor Tremor and Other Hyperkinetic Movements. 7: 1-15; 2017.","DOI":"10.5334\/tohm.383"},{"key":"10.1016\/j.spen.2018.02.003_bib12","unstructured":"Genereviews 1993-2018. GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1508\/; February 21, 2002."},{"key":"10.1016\/j.spen.2018.02.003_bib13","series-title":"Swaimann\u2019s Pediatric Neurology: Principles and Practice","first-page":"706","article-title":"Movement disorders: An overview","author":"Mink","year":"2017"},{"key":"10.1016\/j.spen.2018.02.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci7080103","article-title":"Review: myoclonic disorders","volume":"7","author":"Eberhardt","year":"2017","journal-title":"Brain Sci"},{"key":"10.1016\/j.spen.2018.02.003_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10545-014-9723-6","article-title":"Parkinsonism and inborn errors of metabolism","volume":"37","author":"Garcia-Cazorla","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ana.10784","article-title":"Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency","volume":"55","author":"Kolker","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajmg.c.30088","article-title":"Glutaric acidemia type 1","volume":"142C","author":"Hedlund","year":"2006","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10545-006-0451-4","article-title":"Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I)","volume":"30","author":"Kolker","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib19","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/mds.22313","article-title":"Spectrum of movement disorders associated with glutaric aciduria type 1: A study of 16 patients","volume":"23","author":"Gitiaux","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2018.02.003_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1203\/01.pdr.0000219387.79887.86","article-title":"Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency","volume":"59","author":"Kolker","year":"2006","journal-title":"Pediatr Res"},{"key":"10.1016\/j.spen.2018.02.003_bib21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1023\/B:BOLI.0000045776.50573.52","article-title":"Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: Anticholinergic drugs and botulinum toxin as additional therapeutic options","volume":"27","author":"Burlina","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib22","first-page":"3S15","article-title":"Glucose transporter 1 deficiency syndrome and other glycolytic defects","volume":"17","author":"De Vivo","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00431-002-0939-3","article-title":"Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: Impaired glucose transport into the brain\u2014a review","volume":"161","author":"Klepper","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.spen.2018.02.003_bib24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaneurol.2013.3090","article-title":"Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: A systematic review","volume":"70","author":"Leen","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib25","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.seizure.2013.07.003","article-title":"GLUT1 deficiency syndrome 2013: Current state of the art","volume":"22","author":"De Giorgis","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.spen.2018.02.003_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejmg.2015.06.007","article-title":"From splitting Glut1 deficiency syndromes to overlapping phenotypes","volume":"58","author":"Hully","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0883073814531822","article-title":"Long-term clinical course of Glut I deficiency syndrome","volume":"30","author":"Alter","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0883073814531822","article-title":"Long-term clinical course of Glut1 deficiency syndrome","volume":"30","author":"Alter","year":"2015","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib29","unstructured":"Genereviews 1993-2018. Glucose transporter type 1 deficiency syndrome. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1430\/; July 30, 2002."},{"key":"10.1016\/j.spen.2018.02.003_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson\u2019s disease","volume":"369","author":"Ala","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2018.02.003_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ng1293-344","article-title":"The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene","volume":"5","author":"Tanzi","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng0295-210","article-title":"The Wilson disease gene: Spectrum of mutations and their consequences","volume":"9","author":"Thomas","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/humu.20586","article-title":"Sequence variation database for the Wilson disease copper transporter, ATP7B","volume":"28","author":"Kenney","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.spen.2018.02.003_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1478-3231.2010.02354.x","article-title":"Long-term follow-up of Wilson disease: natural history, treatment, mutations analysis and phenotypic correlation","volume":"31","author":"Bruha","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.spen.2018.02.003_bib36","series-title":"Fenichel\u2019s Clinical Pediatric Neurology","first-page":"277","article-title":"Movement disorders","author":"Pina-Garza","year":"2013"},{"key":"10.1016\/j.spen.2018.02.003_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/0022-3859.41816","article-title":"Kayser-Fleischer ring","volume":"54","author":"Suvarna","year":"2008","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.spen.2018.02.003_bib38","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: An update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.spen.2018.02.003_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.parkreldis.2016.01.024","article-title":"Subclinical neurological involvement does not develop if Wilson\u2019s disease is treated early","volume":"24","author":"Dubbioso","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.spen.2018.02.003_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.48.6.849","article-title":"Wilson\u2019s disease with severe hepatic insufficiency: Beneficial effects of early administration of d-penicillamine","volume":"48","author":"Durand","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.spen.2018.02.003_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-2143(03)00157-4","article-title":"Treatment of Wilson\u2019s disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc","volume":"142","author":"Askari","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.spen.2018.02.003_bib42","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.23182","article-title":"Long-term exclusive zinc monotherapy in symptomatic Wilson disease: experience in 17 patients","volume":"50","author":"Linn","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.spen.2018.02.003_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1203\/00006450-199502000-00016","article-title":"Plasma copper and antioxidant status in Wilson\u2019s disease","volume":"37","author":"Ogihara","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/j.spen.2018.02.003_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-444-63625-6.00016-1","article-title":"Liver transplantation for Wilson disease","volume":"142","author":"Ahmad","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.brs.2016.07.009","article-title":"Deep brain stimulation in rare inherited dystonias","volume":"9","author":"Beaulieu-Boire","year":"2016","journal-title":"Brain Stimul"},{"key":"10.1016\/j.spen.2018.02.003_bib46","unstructured":"Genereviews 1993-2018. Nuclear gene-encoded Leigh syndrome overview. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK320989\/; October 1, 2015."},{"key":"10.1016\/j.spen.2018.02.003_bib47","unstructured":"Genereviews 1993-2018. Mitochondrial DNA-associated Leigh syndrome and NARP. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1173\/; October 30, 2003."},{"key":"10.1016\/j.spen.2018.02.003_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1750-1172-8-96","article-title":"SURF1 deficiency: A multi-centre natural history study","volume":"8","author":"Wedatilake","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10038-008-0289-8","article-title":"Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletions","volume":"53","author":"Yamashita","year":"2008","journal-title":"J Hum Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.410390311","article-title":"Leigh syndrome: Clinical features and biochemical and DNA abnormalities","volume":"39","author":"Rahman","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: One disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.0b013e31827deb4c","article-title":"Biotin-responsive basal ganglia disease revisited: Clinical, neuroradiological, and genetic findings","volume":"80","author":"Tabarki","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2018.02.003_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11940-003-0038-4","article-title":"Biotinidase deficiency: New directions and practical concerns","volume":"5","author":"Wolf","year":"2003","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib54","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-014-9749-9","article-title":"Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency","volume":"38","author":"Desbats","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib55","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1523\/JNEUROSCI.22-21-09203.2002","article-title":"Barbiturates induce mitochondrial depolarization and potentiate excitotoxic neuronal death","volume":"22","author":"Anderson","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.spen.2018.02.003_bib56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/01.wnl.0000196641.05913.27","article-title":"Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial","volume":"66","author":"Kaufmann","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2018.02.003_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/gim.2014.177","article-title":"Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"17","author":"Parikh","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2018.02.003_bib58","first-page":"1","article-title":"On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation","author":"Tello","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib59","unstructured":"Genereviews 1993-2018. Neurodegeneration with brain iron accumulation. [Updated 2014 Apr 24]. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK121988\/; February 28, 2013."},{"key":"10.1016\/j.spen.2018.02.003_bib60","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2004.07.012","article-title":"Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene","volume":"225","author":"Yamashita","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.spen.2018.02.003_bib61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1468-1331.1999.640509.x","article-title":"Generalized freezing in Hallervorden-Spatz syndrome: Case report","volume":"6","author":"Guimar\u00e3es","year":"1999","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib62","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/brain\/awt095","article-title":"\u03b2-Propeller protein-associated neurodegeneration: A new X-linked dominant disorder with brain iron accumulation","volume":"136","author":"Hayflick","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.spen.2018.02.003_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajhg.2013.11.008","article-title":"Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation","volume":"94","author":"Dusi","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2018.02.003_bib64","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.20511","article-title":"Kufor Rakeb disease: Autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia","volume":"20","author":"Williams","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.spen.2018.02.003_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/brb3.8","article-title":"Eye-of-the-tiger sign is not pathognomonic of pantothenate kinase-associated neurodegeneration in adult cases","volume":"1","author":"Chang","year":"2011","journal-title":"Brain Behav"},{"key":"10.1016\/j.spen.2018.02.003_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awq022","article-title":"Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation","volume":"133","author":"Timmermann","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.spen.2018.02.003_bib67","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0883073807302619","article-title":"The pediatric neurotransmitter disorders","volume":"22","author":"Pearl","year":"2007","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0234-9","article-title":"Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: A retrospective cohort study","volume":"10","author":"Mercimek-Mahmutoglu","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2018.02.003_bib69","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/ana.10628","article-title":"Approach to diagnosis of neurotransmitter diseases exemplified by the differential diagnosis of childhood-onset dystonia","volume":"54","author":"Assman","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib70","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/01.WNL.0000142083.47927.0A","article-title":"Long-term course of L-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency","volume":"63","author":"Schiller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2018.02.003_bib71","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/brain\/awq087","article-title":"Tyrosine hydroxylase deficiency: A treatable disorder of brain catecholamine biosynthesis","volume":"133","author":"Willemsen","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.spen.2018.02.003_bib72","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.22685","article-title":"Sepiapterin reductase deficiency: A treatable mimic of cerebral palsy","volume":"71","author":"Friedman","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2018.02.003_bib73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2005.09.028","article-title":"Long-term follow-up of Chinese patients who received delayed treatment for 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"87","author":"Lee","year":"2006","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2018.02.003_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/WNL.0b013e3181e620ae","article-title":"Clinical and biochemical features of aromatic l-amino acid decarboxylase deficiency","volume":"75","author":"Brun","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2018.02.003_bib75","series-title":"Atlas of Metabolic Diseases","author":"Nyhan","year":"2005"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909118300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909118300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T06:34:39Z","timestamp":1660458879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909118300056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":75,"alternative-id":["S1071909118300056"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2018.02.003","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Movement Disorders and Neurometabolic Diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}